CMMB
Chemomab Therapeutics Ltd.
-0.02 (-0.57%)2.64USD41.6K成交股數–市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。外國發行人(20-F)通常只申報半年或年度,逐季會有缺。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 25Q2 | 25Q1 | 24Q2 | 24Q1 | 23Q2 | 23Q1 | 22Q3 | 22Q2 | 22Q1 | 21Q4 | 21Q3 | 21Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | – | – | 2.9M | – | 5.0M | 6.9M | 5.4M | 2.9M | 2.7M | 2.4M | 1.5M | 1.3M |
| 銷售管理費用 | – | – | 840K | – | 3.2M | 2.2M | 2.9M | 3.3M | 2.6M | 2.6M | 1.4M | 1.4M |
| 營業利益 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −2.1M-74% | −3.3M-62% | −3.6M-55% | −3.9M-38% | −8.0M+56% | −8.8M+74% | −8.1M+172% | −6.2M+123% | −5.1M | −5.0M | −3.0M | −2.8M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | – | – | 0.01-63% | – | 0.04+64% | 0.04+74% | 0.04+169% | 0.03+108% | 0.02 | 0.02 | 0.01 | 0.01 |
| 稀釋股數 | – | – | 286M | – | 222M | 221M | 229M | 228M | 228M | 207M | 228M | 216M |
資產負債表 期末餘額
| 科目 | 25Q2 | 25Q1 | 24Q2 | 24Q1 | 23Q2 | 23Q1 | 22Q3 | 22Q2 | 22Q1 | 21Q4 | 21Q3 | 21Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 5.4M | – | 5.0M | – | 10.4M | 20.8M | 10.7M | 9.9M | 13.8M | 15.2M | 37.7M | 45.4M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 11.1M | – | 14.5M | – | 28.8M | 35.0M | 50.2M | 56.4M | 61.0M | 64.4M | 67.4M | 70.5M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 1.4M | – | 4.6M | – | 6.9M | 7.1M | 5.6M | 4.5M | 3.7M | 2.9M | 1.9M | 2.5M |
| 股東權益 | 9.7M | 10.4M | 10.0M | 13.3M | 22.0M | 28.0M | 44.6M | 51.8M | 57.2M | 61.5M | 65.5M | 68.0M |
| 負債比 | 12.8% | – | 31.3% | – | 23.8% | 20.2% | 11.1% | 8.1% | 6.1% | 4.5% | 2.9% | 3.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 25Q2 | 25Q1 | 24Q2 | 24Q1 | 23Q2 | 23Q1 | 22Q3 | 22Q2 | 22Q1 | 21Q4 | 21Q3 | 21Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | – | – | – | −7.2M | – | – | −3.7M | – | – | – |
| 資本支出 | – | – | – | – | – | 1K | – | – | 14K | – | – | – |
| 自由現金流 | – | – | – | – | – | −7.2M | – | – | −3.7M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −9.0M | –% | 0.02 | −11.1M |
| FY2024 | – | – | −13.9M | –% | 0.04 | −15.4M |
| FY2023 | – | – | −24.2M | –% | 0.10 | −23.6M |
| FY2022 | – | – | −27.6M | –% | 0.12 | −20.4M |
| FY2021 | – | – | −12.5M | –% | 0.06 | −12.6M |
| FY2020 | – | – | −6.0M | –% | 0.04 | −5.3M |
| FY2019 | – | – | −27.1M | –% | 0.79 | −16.6M |
| FY2018 | – | – | −13.8M | –% | 1.09 | −14.4M |